{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:03:47Z","timestamp":1790877827541,"version":"4.1.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1038\/ajg.2016.542","type":"journal-article","created":{"date-parts":[[2016,12,6]],"date-time":"2016-12-06T08:03:19Z","timestamp":1481011399000},"page":"365-374","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea"],"prefix":"10.14309","volume":"112","author":[{"given":"Brooks D","family":"Cash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian E","family":"Lacy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip S","family":"Schoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard S","family":"Dove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S","family":"Covington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-29-20210210","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jama.2015.0954","article-title":"Irritable bowel syndrome: a clinical review.","volume":"313","author":"Chey","year":"2015","journal-title":"JAMA"},{"key":"R2-29-20210210","first-page":"71","article-title":"The epidemiology of irritable bowel syndrome.","volume":"6","author":"Canavan","year":"2014","journal-title":"Clin Epidemiol"},{"key":"R3-29-20210210","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cgh.2012.02.029","article-title":"Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.","volume":"10","author":"Lovell","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R4-29-20210210","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/MCG.0b013e318247157c","article-title":"A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome.","volume":"46","author":"Quigley","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"R5-29-20210210","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/nmo.12220","article-title":"Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern.","volume":"26","author":"Su","year":"2014","journal-title":"Neurogastroenterol Motil"},{"key":"R6-29-20210210","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1038\/ajg.2009.232","article-title":"Developing valid and reliable health utilities in irritable bowel syndrome: results from the IBS PROOF Cohort.","volume":"104","author":"Spiegel","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R7-29-20210210","doi-asserted-by":"crossref","first-page":"299","DOI":"10.18553\/jmcp.2004.10.4.299","article-title":"The burden of illness of irritable bowel syndrome: current challenges and hope for the future.","volume":"10","author":"Hulisz","year":"2004","journal-title":"J Manag Care Pharm"},{"key":"R8-29-20210210","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.clinthera.2006.10.010","article-title":"Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study.","volume":"28","author":"Pare","year":"2006","journal-title":"Clin Ther"},{"key":"R9-29-20210210","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/j.gastro.2008.12.015","article-title":"Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases.","volume":"136","author":"Everhart","year":"2009","journal-title":"Gastroenterology"},{"key":"R10-29-20210210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.gtc.2010.12.013","article-title":"The effect of irritable bowel syndrome on health-related quality of life and health care expenditures.","volume":"40","author":"Agarwal","year":"2011","journal-title":"Gastroenterol Clin North Am"},{"key":"R13-29-20210210","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1001\/archinte.161.14.1733","article-title":"A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome.","volume":"161","author":"Camilleri","year":"2001","journal-title":"Arch Intern Med"},{"key":"R14-29-20210210","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1111\/j.1572-0241.2001.04128.x","article-title":"Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome.","volume":"96","author":"Lembo","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R15-29-20210210","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1004409","article-title":"Rifaximin therapy for patients with irritable bowel syndrome without constipation.","volume":"364","author":"Pimentel","year":"2011","journal-title":"N Engl J Med"},{"key":"R17-29-20210210","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/gut.28.2.156","article-title":"Irritable bowel-type symptoms in spontaneous and induced constipation.","volume":"28","author":"Marcus","year":"1987","journal-title":"Gut"},{"key":"R19-29-20210210","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2982.2004.00513.x","article-title":"Opioids and the gut: pharmacology and current clinical experience.","volume":"16","author":"De Schepper","year":"2004","journal-title":"Neurogastroenterol Motil"},{"key":"R20-29-20210210","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1476-5381.2012.02068.x","article-title":"Modulation of gastrointestinal function by MuDelta, a mixed opioid receptor agonist opioid receptor antagonist.","volume":"167","author":"Wade","year":"2012","journal-title":"Br J Pharmacol"},{"key":"R21-29-20210210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.regpep.2009.03.012","article-title":"Opioid receptors in the gastrointestinal tract.","volume":"155","author":"Holzer","year":"2009","journal-title":"Regul Pept"},{"key":"R22-29-20210210","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1053\/j.gastro.2013.04.006","article-title":"Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.","volume":"145","author":"Dove","year":"2013","journal-title":"Gastroenterology"},{"key":"R23-29-20210210","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa1505180","article-title":"Eluxadoline for irritable bowel syndrome with diarrhea.","volume":"374","author":"Lembo","year":"2016","journal-title":"N Engl J Med"},{"key":"R24-29-20210210","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1053\/j.gastro.2006.03.008","article-title":"The functional gastrointestinal disorders and the Rome III process.","volume":"130","author":"Drossman","year":"2006","journal-title":"Gastroenterology"},{"key":"R25-29-20210210","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11894-015-0455-z","article-title":"Sphincter of Oddi dysfunction: updates from the recent literature.","volume":"17","author":"Yaghoobi","year":"2015","journal-title":"Curr Gastroenterol Rep"},{"key":"R26-29-20210210","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/gutjnl-2012-302779","article-title":"Classification of acute pancreatitis2012: revision of the Atlanta classification and definitions by international consensus.","volume":"62","author":"Banks","year":"2013","journal-title":"Gut"},{"key":"R28-29-20210210","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s11894-001-0015-6","article-title":"Gallbladder sludge: what is its clinical significance?","volume":"3","author":"Shaffer","year":"2001","journal-title":"Curr Gastroenterol Rep"},{"key":"R29-29-20210210","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.3748\/wjg.v20.i22.6725","article-title":"Gender-related differences in irritable bowel syndrome: potential mechanisms of sex hormones.","volume":"20","author":"Meleine","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R30-29-20210210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ajgsup.2014.5","article-title":"Molecular physiology of enteric opioid receptors.","volume":"2","author":"Galligan","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R31-29-20210210","first-page":"589","article-title":"Loperamide-induced acute pancreatitis.","volume":"24","author":"Howaizi","year":"2000","journal-title":"Gastroenterol Clin Biol"},{"key":"R32-29-20210210","first-page":"517414","article-title":"Loperamide-induced acute pancreatitis.","volume":"2013","author":"Vidarsdottir","year":"2013","journal-title":"Case Rep Gastrointest Med"},{"key":"R33-29-20210210","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.cgh.2006.11.023","article-title":"Drug-induced acute pancreatitis: an evidence-based review.","volume":"5","author":"Badalov","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R34-29-20210210","first-page":"581","article-title":"Drug-induced acute pancreatitis in a cohort of 328 patients. A single-centre experience from Australia.","volume":"12","author":"Barreto","year":"2011","journal-title":"JOP"},{"key":"R35-29-20210210","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/gut.41.5.705","article-title":"Pancreatitis induced by codeine: a case report with positive rechallenge.","volume":"41","author":"Hastier","year":"1997","journal-title":"Gut"},{"key":"R36-29-20210210","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1111\/j.1572-0241.2000.03213.x","article-title":"A new source of drug-induced acute pancreatitis: codeine.","volume":"95","author":"Hastier","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"R37-29-20210210","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/01.mcg.0000173929.60115.b4","article-title":"Drug-induced pancreatitis: an update.","volume":"39","author":"Trivedi","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"R38-29-20210210","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4103\/2229-5151.158416","article-title":"Prior cholecystectomy predisposes to acute pancreatitis in codeine-prescribed patients.","volume":"5","author":"Turkmen","year":"2015","journal-title":"Int J Crit Illn Inj Sci"},{"key":"R39-29-20210210","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1136\/gut.29.10.1402","article-title":"Effects of morphine on the human sphincter of Oddi.","volume":"29","author":"Helm","year":"1988","journal-title":"Gut"},{"key":"R40-29-20210210","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0016-5085(84)90599-7","article-title":"Neural control of the sphincter of Oddi. Physiologic role of enkephalins on the regulation of basal sphincter of Oddi motor activity in the cat.","volume":"86","author":"Behar","year":"1984","journal-title":"Gastroenterology"},{"key":"R41-29-20210210","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1042\/cs0820169","article-title":"Location of enkephalinase and functional effects of Leu5enkephalin and inhibition of enkephalinase in the feline main pancreatic and bile duct sphincters.","volume":"82","author":"Thune","year":"1992","journal-title":"Clin Sci (Lond)"},{"key":"R42-29-20210210","first-page":"1270","article-title":"Naloxone reverses pattern of obstruction of the distal common bile duct induced by analgesic narcotics in hepatobiliary imaging.","volume":"32","author":"Patch","year":"1991","journal-title":"J Nucl Med"},{"key":"R43-29-20210210","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/j.1572-0241.2001.03536.x","article-title":"Narcotic analgesic effects on the sphincter of Oddi: a review of the data and therapeutic implications in treating pancreatitis.","volume":"96","author":"Thompson","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R44-29-20210210","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/0016-5085(80)90675-7","article-title":"The morphine-prostigmin provocative testis it useful for making clinical decisions?","volume":"78","author":"Steinberg","year":"1980","journal-title":"Gastroenterology"},{"key":"R45-29-20210210","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/archinte.1962.03620160055008","article-title":"Serum enzyme activities following morphine. A study of transaminase and alkaline phosphatase levels in normal persons and those with gallbladder disease.","volume":"109","author":"Mossberg","year":"1962","journal-title":"Arch Intern Med"},{"key":"R46-29-20210210","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1440-1746.1989.tb00842.x","article-title":"Relationship between morphine responses and sphincter of Oddi motility in undefined biliary pain after cholecystectomy.","volume":"4","author":"Roberts-Thomson","year":"1989","journal-title":"J Gastroenterol Hepatol"},{"key":"R47-29-20210210","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/gut.41.3.371","article-title":"Influence of cholecystectomy on sphincter of Oddi motility.","volume":"41","author":"Luman","year":"1997","journal-title":"Gut"},{"key":"R49-29-20210210","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1572-0241.2005.40793.x","article-title":"Marked elevation in serum transaminases: an atypical presentation of choledocholithiasis.","volume":"100","author":"Nathwani","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R50-29-20210210","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF02774229","article-title":"Effect of long term alcohol feeding on the pancreas in rat.","volume":"14","author":"Kagaya","year":"1979","journal-title":"Gastroenterol Jpn"},{"key":"R51-29-20210210","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000104235","article-title":"Pathobiology of alcoholic pancreatitis.","volume":"7","author":"Pandol","year":"2007","journal-title":"Pancreatology"},{"key":"R52-29-20210210","first-page":"335","article-title":"Oxidative stress and alcoholic pancreatitis.","volume":"2","author":"Shahedi","year":"2013","journal-title":"J Gastroenterol Hepatol Res"},{"key":"R53-29-20210210","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0016-5107(91)70774-8","article-title":"Effect of local instillation of alcohol on sphincter of Oddi motor activity: combined ERCP and manometry study.","volume":"37","author":"Guelrud","year":"1991","journal-title":"Gastrointest Endosc"},{"key":"R54-29-20210210","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/gut.24.1.20","article-title":"Effects of ethanol on the sphincter of Oddi: an endoscopic manometric study.","volume":"24","author":"Viceconte","year":"1983","journal-title":"Gut"},{"key":"R55-29-20210210","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2036.2007.03256.x","article-title":"Pharmacological modulation of gut mucosal and large vessel blood flow.","volume":"25","author":"Kamm","year":"2007","journal-title":"Aliment Pharmacol Ther"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2016542.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2016542","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2016542.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201702000-00029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:27:39Z","timestamp":1786544859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201702000-00029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2016.542","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}